Dr. Wencheng Zhang 章文成
Chief Physician
Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy for esophageal cancer and lung cancer.
Dr. Zhang is a Chief Physician and doctoral supervisor with a PhD from Peking Union Medical College. From 2015 to 2016, Dr. Zhang studied at the University of Texas MD Anderson Cancer Center in the United States. Clinical and basic research focuses on esophageal cancer, with additional clinical research in lung cancer. Dr. Zhang has published multiple SCI articles.
Professional roles
- Vice Chair, Radiotherapy Professional Committee, China Medicine Education Association
- Vice Chair, Youth Committee of Radiotherapy Professional Committee, Chinese Medical Doctor Association
- Vice Chair, Radiotherapy Professional Committee, Tianjin Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhang Wencheng). Papers usually list the name as Wencheng Zhang or Zhang W.
Selected publications
107 papers on PubMed matched by name and affiliation; 20 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Biol Med, 2026 (senior author): Machine learning-based clinical decision support tool for advanced ESCC in the immunotherapy era: a multi-center study. PubMed 41988845
- EClinicalMedicine, 2026 (first author): Iparomlimab and tuvonralimab (QL1706) combined definitive chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma (QL1706-IIT-02): a single arm, phase 2 trial. PubMed 41623855
- J Nanobiotechnology, 2025 (senior author): IL-15 signaling via cis- and trans-presentation to progenitor-exhausted CD8(+) T cells enhances radio-immunotherapy efficacy in ESCC. PubMed 41327181
- Phys Imaging Radiat Oncol, 2025 (senior author): A machine learning approach for radiation pneumonitis prediction in elderly esophageal cancer patients by integrating baseline computed tomography radiomics, dosiomics, and clinical characteristics. PubMed 41333544
- Cancer Lett, 2025 (senior author): Immunochemotherapy plus radiotherapy versus immunochemotherapy alone as first-line treatment for treatment-naïve, advanced esophageal squamous cell carcinoma (AEC-ICR-1st): A multi-center cohort study. PubMed 39736452
- BMC Cancer, 2025 (senior author): Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial. PubMed 40001034
- Expert Opin Biol Ther, 2024 (senior author): Optimization of radiation target volume for locally advanced esophageal cancer in the immunotherapy era. PubMed 39460561
- Cancer Lett, 2024 (senior author): Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies. PubMed 39142497
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion